Clinical Trials Search
Clinical Trial 18756
Cancer Type: Gastrointestinal Tumor
Study Type: Diagnostic
Phase of Study: NA
- Jonathan Strosberg
The Clinical Utility of a Blood-Based Multitranscriptome Assay as a Biomarker for Gastroenteropancreatic and Lung Neuroendocrine Tumors
The purpose of this study is to evaluate how well an investigational blood test performs. The study will look at the sensitivity and specificity of a blood-based multitranscriptome assay (NETest). Participants to be enrolled in the study will be recruited within the Gastrointestinal (GI) Clinic of Moffitt Cancer Center.
The primary objective of this project is: To determine the performance metrics (sensitivity, specificity) of NETest in a real-world heterogenous cohort of NET patients. The secondary objectives of this project are: Evaluate and compare the performance metrics of the NETest in pre-specified sub-cohorts of patients (G1/G2 vs G3; GI vs pNETs vs lung; ENETS stage I-III vs stage IV). Evaluate the ability of the NETest in influencing clinical decisions (when associated to other clinical, lab or imaging results).